{"data":[{"accessionNo":"0000919574-26-005209","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-06-30","reportingPerson":"Sirenia Capital Management LP","reportingCik":null,"personType":"IA,PN","sharesOwned":6565474,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0000919574-26-005209","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-06-30","reportingPerson":"Alex Silverstein","reportingCik":null,"personType":"HC,IN","sharesOwned":6565474,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0001193125-26-352962","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $.01 per share","eventDate":"2026-06-30","reportingPerson":"Ikarian Capital, LLC","reportingCik":null,"personType":"IA","sharesOwned":1555423,"percentOfClass":9.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0001193125-26-352962","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $.01 per share","eventDate":"2026-06-30","reportingPerson":"Neil Shahrestani","reportingCik":null,"personType":"IN,HC","sharesOwned":1555423,"percentOfClass":9.5,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-26-000026","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $.01 per share","eventDate":"2026-06-30","reportingPerson":"Squadron Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-26-000026","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $.01 per share","eventDate":"2026-06-30","reportingPerson":"Squadron Capital Management LLC","reportingCik":null,"personType":"IA,HC","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-26-000026","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $.01 per share","eventDate":"2026-06-30","reportingPerson":"Matthew Sesterhenn","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-26-000026","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $.01 per share","eventDate":"2026-06-30","reportingPerson":"William Blank","reportingCik":null,"personType":"HC,IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0000919574-26-004949","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-06-30","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":730000,"percentOfClass":4.79,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0000919574-26-004949","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-06-30","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":730000,"percentOfClass":4.79,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0000919574-26-004949","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-06-30","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":730000,"percentOfClass":4.79,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-26-000014","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $.01 per share","eventDate":"2026-03-31","reportingPerson":"Matthew Sesterhenn","reportingCik":null,"personType":"HC,IN","sharesOwned":511714,"percentOfClass":6.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-26-000014","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $.01 per share","eventDate":"2026-03-31","reportingPerson":"Squadron Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":511714,"percentOfClass":6.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-26-000014","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $.01 per share","eventDate":"2026-03-31","reportingPerson":"Squadron Capital Management LLC","reportingCik":null,"personType":"IA,HC","sharesOwned":511714,"percentOfClass":6.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-26-000014","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $.01 per share","eventDate":"2026-03-31","reportingPerson":"William Blank","reportingCik":null,"personType":"HC,IN","sharesOwned":511714,"percentOfClass":6.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0001193125-26-226563","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-03-31","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":979815,"percentOfClass":6.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0001193125-26-226563","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-03-31","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":979815,"percentOfClass":6.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0001193125-26-226563","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock, par value $0.01 per share","eventDate":"2026-03-31","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":979815,"percentOfClass":6.1,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0000947871-26-000492","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock","eventDate":"2026-04-16","reportingPerson":"ORBIMED ADVISORS LLC","reportingCik":"0001055951","personType":"IA","sharesOwned":1876198,"percentOfClass":11.9,"filedAt":"2026-05-05","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0000947871-26-000492","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":"68232V884","securityClass":"Common Stock","eventDate":"2026-04-16","reportingPerson":"OrbiMed Capital GP VIII LLC","reportingCik":"0001845804","personType":"OO","sharesOwned":1876198,"percentOfClass":11.9,"filedAt":"2026-05-05","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0001193125-26-055077","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common stock, par value $.01 per share","eventDate":"2025-12-31","reportingPerson":"Ikarian Capital, LLC","reportingCik":null,"personType":"IA","sharesOwned":812524,"percentOfClass":9.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0001193125-26-055077","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common stock, par value $.01 per share","eventDate":"2025-12-31","reportingPerson":"Neil Shahrestani","reportingCik":null,"personType":"IN,HC","sharesOwned":812524,"percentOfClass":9.99,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-26-000009","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $.01 per share","eventDate":"2025-12-31","reportingPerson":"Squadron Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":713540,"percentOfClass":8.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-26-000009","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $.01 per share","eventDate":"2025-12-31","reportingPerson":"Squadron Capital Management LLC","reportingCik":null,"personType":"IA,HC","sharesOwned":713540,"percentOfClass":8.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-26-000009","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $.01 per share","eventDate":"2025-12-31","reportingPerson":"Matthew Sesterhenn","reportingCik":null,"personType":"HC,IN","sharesOwned":713540,"percentOfClass":8.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-26-000009","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $.01 per share","eventDate":"2025-12-31","reportingPerson":"William Blank","reportingCik":null,"personType":"HC,IN","sharesOwned":713540,"percentOfClass":8.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0000902664-26-000911","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-12-31","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":730000,"percentOfClass":9.14,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0000902664-26-000911","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-12-31","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":730000,"percentOfClass":9.14,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0000902664-26-000911","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-12-31","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":730000,"percentOfClass":9.14,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0001493152-26-006134","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001130598","issuerName":"Traws Pharma, INC.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, $0.01 par value","eventDate":"2025-12-31","reportingPerson":"Ayrton Capital LLC","reportingCik":null,"personType":"IA,CO","sharesOwned":342935,"percentOfClass":4.29,"filedAt":"2026-02-11","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0001493152-26-006134","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001130598","issuerName":"Traws Pharma, INC.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, $0.01 par value","eventDate":"2025-12-31","reportingPerson":"Waqas Khatri","reportingCik":null,"personType":"IN","sharesOwned":342935,"percentOfClass":4.29,"filedAt":"2026-02-11","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0001493152-26-006134","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001130598","issuerName":"Traws Pharma, INC.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, $0.01 par value","eventDate":"2025-12-31","reportingPerson":"Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B","reportingCik":null,"personType":"CO","sharesOwned":342935,"percentOfClass":4.29,"filedAt":"2026-02-11","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002042077-26-000007","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common","eventDate":"2026-01-14","reportingPerson":"Chernett Jorey","reportingCik":null,"personType":"IN","sharesOwned":543268,"percentOfClass":6.8,"filedAt":"2026-01-16","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0001193125-25-282836","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-30","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":886887,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0001193125-25-282836","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-30","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":886887,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0001193125-25-282836","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-30","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":886887,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-25-000010","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $.01 per share","eventDate":"2025-09-30","reportingPerson":"William Blank","reportingCik":null,"personType":"HC,IN","sharesOwned":591000,"percentOfClass":8.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-25-000010","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $.01 per share","eventDate":"2025-09-30","reportingPerson":"Squadron Capital Management LLC","reportingCik":null,"personType":"IA,HC","sharesOwned":591000,"percentOfClass":8.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-25-000010","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $.01 per share","eventDate":"2025-09-30","reportingPerson":"Matthew Sesterhenn","reportingCik":null,"personType":"HC,IN","sharesOwned":591000,"percentOfClass":8.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-25-000010","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $.01 per share","eventDate":"2025-09-30","reportingPerson":"Squadron Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":523359,"percentOfClass":7.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0000902664-25-004891","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-30","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":330000,"percentOfClass":4.67,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0000902664-25-004891","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-30","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":330000,"percentOfClass":4.67,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0000902664-25-004891","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $0.01 per share","eventDate":"2025-09-30","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":330000,"percentOfClass":4.67,"filedAt":"2025-11-13","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-25-000006","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $.01 per share","eventDate":"2025-09-12","reportingPerson":"William Blank","reportingCik":null,"personType":"HC,IN","sharesOwned":420501,"percentOfClass":6,"filedAt":"2025-09-19","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-25-000006","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $.01 per share","eventDate":"2025-09-12","reportingPerson":"Squadron Capital Management LLC","reportingCik":null,"personType":"IA,HC","sharesOwned":420501,"percentOfClass":6,"filedAt":"2025-09-19","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-25-000006","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $.01 per share","eventDate":"2025-09-12","reportingPerson":"Matthew Sesterhenn","reportingCik":null,"personType":"HC,IN","sharesOwned":420501,"percentOfClass":6,"filedAt":"2025-09-19","canonicalUrl":"https://xoomar.com/markets/stocks/traw"},{"accessionNo":"0002050709-25-000006","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001130598","issuerName":"Traws Pharma, Inc.","ticker":"TRAW","cusip":null,"securityClass":"Common Stock, par value $.01 per share","eventDate":"2025-09-12","reportingPerson":"Squadron Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":372374,"percentOfClass":5.3,"filedAt":"2025-09-19","canonicalUrl":"https://xoomar.com/markets/stocks/traw"}],"updatedAt":"2026-11-05T14:33:21.338Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/traw","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}